The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance. The Life Sciences Podcasts Series looks at some of the hottest topics in the Life Sciences industry. In this podcast, Finnegan attorneys Jill MacAlpine, Alissa Lipton, Lulu Wang, and Sara Leiman discuss the doctrine of inherency and obviousness and identify notable, recent decisions in the life sciences industry.
To listen to the podcast, please click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.